Edition:
United Kingdom

Merrimack Pharmaceuticals Inc (MACK.OQ)

MACK.OQ on NASDAQ Stock Exchange Global Market

4.00USD
2:36pm GMT
Change (% chg)

$-0.08 (-1.96%)
Prev Close
$4.08
Open
$4.00
Day's High
$4.00
Day's Low
$3.99
Volume
2,179
Avg. Vol
15,204
52-wk High
$11.70
52-wk Low
$3.35

Select another date:

Mon, Jun 25 2018

Merrimack to scrap development of pancreatic cancer treatment

Merrimack Pharmaceuticals Inc said on Monday it would stop developing its experimental treatment for pancreatic cancer after it failed to meet the main and secondary goals in a mid-stage trial.

UPDATE 1-Merrimack to scrap development of pancreatic cancer treatment

June 25 Merrimack Pharmaceuticals Inc said on Monday it would stop developing its experimental treatment for pancreatic cancer after it failed to meet the main and secondary goals in a mid-stage trial.

Merrimack to scrap development of pancreatic cancer treatment

June 25 Merrimack Pharmaceuticals Inc said on Monday it would discontinue the development of an experimental treatment for pancreatic cancer after the drug failed to meet the main and secondary goals of a mid-stage trial.

Select another date: